BioCentury
ARTICLE | Company News

Endo, Penwest deal

August 16, 2010 7:00 AM UTC

Endo will acquire partner Penwest in a tender offer of $5 per share, or about $168 million in cash. The price is a 19% premium to Penwest's close of $4.21 on Aug. 6, before the deal was announced. The boards of both companies have unanimously approved the tender offer, which is expected to close in September. ...